A recent work describes MDL1 and MDL1AS as prognostic biomarkers in rectal cancer and MDL1AS as a diagnostic biomarker for different types of cancer such as those affecting the colon, rectum, breast, and larynx [216]. This evidence concerns the gene CLEC5A and rectal cancer.